BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 37791843)

  • 1. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy.
    Ergönül O; Celikbaş A; Dokuzoguz B; Eren S; Baykam N; Esener H
    Clin Infect Dis; 2004 Jul; 39(2):284-7. PubMed ID: 15307042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamine depletion in patients with Crimean-Congo hemorrhagic fever.
    Aydin H; Engin A; Keleş S; Ertemur Z; Hekim N
    J Med Virol; 2020 Dec; 92(12):2983-2991. PubMed ID: 32281664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and Crimean-Congo Hemorrhagic Fever: Is there any Similarity in Chest Radiology?
    Yapar D; Akdoğan Ö; Boyacı H; Yılmaz YA; Topçu H; Arslan S; Yılmaz B; Kodalak G; Çebi K; Kayadibi H; Çelikbaş AK; Gülhan M; Baykam N
    Infect Dis Clin Microbiol; 2022 Mar; 4(1):1-6. PubMed ID: 38633543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. We Need More Accuracy in Crimean-Congo Hemorrhagic Fever Diagnosis upon Initial Presentation in Endemic Areas.
    Bozkurt I
    Vector Borne Zoonotic Dis; 2024 May; ():. PubMed ID: 38770687
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study between Ribavirin and Ribavirin plus Intravenous Immunoglobulin against Crimean Congo hemorrhagic fever.
    Salehi H; Salehi M; Adibi N; Salehi M
    J Res Med Sci; 2013 Jun; 18(6):497-500. PubMed ID: 24250699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urgent call for holistic action: Addressing the Crimean-Congo hemorrhagic fever (CCHF) crisis in Pakistan's healthcare system.
    Kumar H; Qureshi AA; Minhaj A; Kumar B
    New Microbes New Infect; 2024; 60-61():101418. PubMed ID: 38770233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosensor-based methods for Crimean-Congo hemorrhagic fever virus detection.
    Zandi M; Rasooli A; Soltani S; Teymouri S; Mohammadi S; Abbasi S
    J Vector Borne Dis; 2021; 58(4):383-385. PubMed ID: 35381829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of Crimean-Congo hemorrhagic fever.
    Tezer H; Polat M
    Expert Rev Anti Infect Ther; 2015 May; 13(5):555-66. PubMed ID: 25746112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of seroprevalence and clinical and laboratory findings of patients admitted to health institutions in Gümüşhane with suspicion of Crimean-Congo hemorrhagic fever.
    Gürbüz E; Ekici A; Ünlü AH; Yılmaz H
    Turk J Med Sci; 2021 Aug; 51(4):1825-1832. PubMed ID: 33754650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions.
    Ozturk B; Tutuncu E; Kuscu F; Gurbuz Y; Sencan I; Tuzun H
    Int J Infect Dis; 2012 Feb; 16(2):e89-93. PubMed ID: 22154082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Role of Blood Urea Nitrogen and C-Reactive Protein and Their Ratios to Albumin in Predicting Mortality in Crimean-Congo Hemorrhagic Fever].
    Karaşahin Ö; İnan Sarıkaya R
    Mikrobiyol Bul; 2023 Jul; 57(3):419-431. PubMed ID: 37462305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey.
    Hatipoglu CA; Bulut C; Yetkin MA; Ertem GT; Erdinc FS; Kilic EK; Sari T; Kinikli S; Oral B; Demiroz AP
    Scand J Infect Dis; 2010 Jul; 42(6-7):516-21. PubMed ID: 20166862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the associations between endothelial dysfunction, inflammation and coagulation in Crimean-Congo hemorrhagic fever patients.
    Doğan HO; Büyüktuna SA; Kapancik S; Bakir S
    Arch Virol; 2018 Mar; 163(3):609-616. PubMed ID: 29159591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive epidemiological, clinical and laboratory parameters in the diagnosis of Crimean-Congo hemorrhagic fever.
    Kaygusuz TÖ; Tartar AS; Balin ŞÖ; Akbulut A; Demirdağ K
    Biomark Med; 2023 Jun; 17(11):533-540. PubMed ID: 37791843
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.